MRK and RVMD Related Headlines
Go Back- Truist Securities keeps Revolution (RVMD) at Buy, 'believe that RVMD is well funded and doesn't need to do a deal'
- Revolution Medicines stock falls after Merck reportedly ends acquisition pursuit
- Merck ends acquisition talks with Revolution Medicines - WSJ
- STAT reported Feuerstein: meeting with Revolution Medicines CEO cancelled
- Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ
- Revolution Medicines (RVMD) CEO Said to Cancel Upcoming Meetings Amid M&A Chatter
- After-hours movers: Rocket Companies, General Motors, Intel, and more
- Merck Discussed $28B-$32B Price For Revolution Medicines - FT
- Revolution Medicines stock rises on Merck acquisition talks
- Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT
